Wound - in Medical Care
Conditions
Keywords
woundcare community nursing competence
Brief summary
This study is designed to investigate whether the adoption of the use of a range of wound care products from a single manufacturer makes training in appropriate product selection more effective and results in more accurate selection of the appropriate product for the wound and for the patient's lifestyle, thereby incurring less waste and reducing the number of referrals by the community nursing team to the Tissue Viability Team. One community nursing team will switch to using a full range of dressings and compression products from BSN medical UK for three months. Nurse training on the products will be given and nurse competencies and confidence in woundcare and appropriate product selection will be tested at the start and end of the study. The number and type of referrals to the Tissue Viability Team will be measured. Total anonymised data on numbers of referrals, wound closure, numbers of wounds and quantity and cost of products used will be collected and compared with the historical record for three months prior to the study. Patients will complete a Quality of Life questionnaire at enrolment and exit from the study. Patients for whom BSN medical UK products are not appropriate or not desired by the patient will not be enrolled and will receive the usual range of products available to the community nursing team.
Interventions
OTHERUse of wound care products from a single manufacturer
The participating Healthcare Professionals will be asked to use BSN medical wound care products for the study duration
Sponsors
BSN Medical Ltd. UK
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
All healthcare professionals of the Billericay team responsible for dressing changes who are willing to take part in this study and give their written informed consent. Inclusion Criteria for the patients: * Patients giving their informed consent and with an open wound being treated by the community nursing team * All patients whose wounds can be treated with BSN medical UK Product range for wound and leg ulcer management.
Exclusion criteria
for the patients: * Age \<18 years * Subjects who do not give their consent for any reason * Subjects who are unable to read and understand patient information sheet and consent form
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Incidence of inappropriate use of dressings for the wound condition and patient lifestyle | At the end of 12 weeks treatment period | As measured by referrals for case review to the Tissue Viability Team during the study |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Wound types treated | At the end of 12 weeks treatment period | — |
| Total number of wound closure occurred | At the end of 12 weeks treatment period | — |
| Average duration of treatment | At the end of 12 weeks treatment period | — |
| Patients Quality of Life living with a Wound | At the start of the study and at the end of 12 weeks treatment period | as measured by use of the validated questionnaire Wound QoL. |
| Confidence of healthcare professionals in their dressing selection | At the start of the study and at the end of 12 weeks treatment period | as measured by written assessment |
| Visual Analogue Scoring by the healthcare professionals of the simplification of training | At the end of 12 weeks treatment period | — |
| Number of patients with wounds treated | At the end of 12 weeks treatment period | — |
| NHS Trainer's time | At the end of 12 weeks treatment period | — |
| NHS Trainer's cost | At the end of 12 weeks treatment period | — |
| Nurse's concordance with training measured by the total number of referrals to the tissue viability team caused by inappropriate dressing selections defined by the trust's guidelines | At the end of 12 weeks treatment period | — |
| Costs of dressings used | At the end of 12 weeks treatment period | — |
| Number of wounds which could not be treated by the integrated range | At the end of 12 weeks treatment period | — |
| Condition of wounds which could not be treated by the integrated range | At the end of 12 weeks treatment period | — |
| Time required for training | At the end of 12 weeks treatment period | — |
Countries
United Kingdom
Outcome results
None listed